Sisram Medical Ltd
HKEX:1696.HK
3.46 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 359.292 | 354.48 | 294.294 | 162.095 | 173.52 | 153.919 | 136.887 | 118.156 | 110.406 | 101.321 |
Cost of Revenue
| 139.767 | 152.254 | 127.433 | 71.794 | 77.646 | 71.622 | 63.69 | 55.933 | 53.043 | 49.459 |
Gross Profit
| 219.525 | 202.226 | 166.861 | 90.301 | 95.874 | 82.297 | 73.197 | 62.223 | 57.363 | 51.862 |
Gross Profit Ratio
| 0.611 | 0.57 | 0.567 | 0.557 | 0.553 | 0.535 | 0.535 | 0.527 | 0.52 | 0.512 |
Reseach & Development Expenses
| 18.029 | 18.023 | 15.594 | 10.957 | 10.47 | 10.38 | 12.399 | 7.307 | 7.069 | 6.869 |
General & Administrative Expenses
| 34.092 | 29.075 | 21.815 | 15.874 | 15.833 | 14.774 | 13.862 | 12.989 | 11.121 | 10.166 |
Selling & Marketing Expenses
| 125.345 | 99.684 | 78.893 | 43.085 | 43.496 | 32.662 | 26.059 | 21.38 | 18.59 | 16.646 |
SG&A
| 159.437 | 128.759 | 100.708 | 58.959 | 59.329 | 47.436 | 39.921 | 34.369 | 29.711 | 26.812 |
Other Expenses
| 0 | -9.322 | -7.61 | -0.012 | -2.902 | -2.863 | -1.78 | -2.438 | -2.798 | -1.803 |
Operating Expenses
| 177.466 | 146.782 | 116.302 | 69.904 | 69.799 | 57.816 | 52.32 | 41.676 | 36.78 | 33.681 |
Operating Income
| 38.026 | 46.214 | 43.185 | 17.387 | 25.003 | 24.481 | 20.877 | 20.547 | 20.583 | 18.181 |
Operating Income Ratio
| 0.106 | 0.13 | 0.147 | 0.107 | 0.144 | 0.159 | 0.153 | 0.174 | 0.186 | 0.179 |
Total Other Income Expenses Net
| -0.896 | -1.167 | -1.089 | -0.725 | -1.236 | -1.697 | -5.056 | -8.687 | -9.656 | -8.858 |
Income Before Tax
| 37.13 | 44.242 | 41.672 | 16.662 | 24.839 | 22.784 | 15.821 | 11.86 | 10.927 | 9.323 |
Income Before Tax Ratio
| 0.103 | 0.125 | 0.142 | 0.103 | 0.143 | 0.148 | 0.116 | 0.1 | 0.099 | 0.092 |
Income Tax Expense
| 4.232 | 4.162 | 9.152 | 1.982 | 2.904 | 0.953 | 4.772 | 3.359 | 2.334 | 2.618 |
Net Income
| 31.499 | 40.17 | 31.245 | 13.344 | 20.785 | 21.831 | 11.049 | 8.055 | 7.814 | 5.943 |
Net Income Ratio
| 0.088 | 0.113 | 0.106 | 0.082 | 0.12 | 0.142 | 0.081 | 0.068 | 0.071 | 0.059 |
EPS
| 0.067 | 0.086 | 0.069 | 0.03 | 0.047 | 0.049 | 0.039 | 0.036 | 0.019 | 0.015 |
EPS Diluted
| 0.067 | 0.086 | 0.069 | 0.03 | 0.047 | 0.049 | 0.039 | 0.036 | 0.019 | 0.015 |
EBITDA
| 53.429 | 58.379 | 55.962 | 28.188 | 35.293 | 29.548 | 27.016 | 24.433 | 23.761 | 22.077 |
EBITDA Ratio
| 0.149 | 0.165 | 0.188 | 0.172 | 0.2 | 0.19 | 0.196 | 0.204 | 0.213 | 0.218 |